Search

Gregory F Okasinski

from Wadsworth, IL
Age ~77
Get Report
Also known as:
Kosinski O Gregory, Gregory I
Phone and address:
38850 Northwoods Dr, Beach Park, IL 60083
(847) 244-7592
Related to:
Elizabeth Anne Anderson, 59Darnell A HazelTimothy W Stanard, 59Jennifer Mortensen, 39Kimberly K Stanard, 52Timothy D Mortensen, 41Christine K Okasinski, 76Geoffrey J Okasinski, 43Samantha C Okasinski, 36
Connected to:
Maureen M Okasinski, 56Gary S Okawa, 68Jill M Okawa, 43Joann F Okawa, 62Megumi M Okawa, 56Yohei Okawa, 43David H Okawachi, 70Gloria N Okawara, 63Berit Okay, 60Jennifer Okay, 40

Gregory Okasinski Phones & Addresses

  • 38850 Northwoods Dr, Wadsworth, IL 60083 (847) 244-7592
  • Zion, IL
  • Holtsville, NY
  • Chicago, IL
  • 38850 N Northwoods Dr, Wadsworth, IL 60083 (847) 525-0358

Work

Position: Protective Service Occupations

Publications

Us Patents

Dna Encoding Human A Erythropoietin Analog

View page
US Patent:
58887725, Mar 30, 1999
Filed:
Oct 23, 1995
Appl. No.:
8/537754
Inventors:
Gregory F. Okasinski - Wadsworth IL
Peter J. DeVries - Des Plaines IL
Berry S. Mellovitz - Chicago IL
Joseph L. Meuth - Libertyville IL
Verlyn G. Schaefer - Libertyville IL
Assignee:
Abbott Laboratories - Abbott Park IL
International Classification:
C12N 1519
C12N 1563
C12N 1510
C07K 14505
US Classification:
435 695
Abstract:
Analogs of human erythropoietin, including the �X. sup. 33, Cys. sup. 139, des-Arg. sup. 166 ! and �Cys. sup. 139, des-Arg. sup. 166 ! analogs, as well as methods for making and using such analogs and pharmaceutical compositions containing the same.

Hsv Helper Virus Independent Vector

View page
US Patent:
49701550, Nov 13, 1990
Filed:
Nov 23, 1988
Appl. No.:
7/277458
Inventors:
Gregory F. Okasinski - Zion IL
Assignee:
Abbott Laboratories - Abbott Park IL
International Classification:
C12N 510
C12N 701
C12N 1538
C12N 1586
US Classification:
4351723
Abstract:
This invention encompasses an eukaryotic expression vector constructed from a prokaryotic plasmid by inserting into the prokaryotic plasmid a mediator sequence and a promoter/regulatory sequence with a restriction endonuclease site for inserting a gene to be expressed. The gene to be expressed is inserted into the restriction endonuclease site in the promoter/regulatory sequence and the resulting plasmid is in turn used to transform a eukaryotic cell. The gene is expressed with or without viral mediation.

Hepatitis C Virus Second Envelope (Hcv-E2) Glycoprotein Expression System

View page
US Patent:
60201223, Feb 1, 2000
Filed:
Jun 7, 1995
Appl. No.:
8/478073
Inventors:
Gregory F. Okasinski - Wadsworth IL
Verlyn G. Schaefer - Libertyville IL
Thomas S. Suhar - Lindenhurst IL
Richard R. Lesniewski - Kenosha WI
Assignee:
Abbott Laboratories - Abbott Park IL
International Classification:
C12Q 170
US Classification:
435 5
Abstract:
This invention provides a novel mammalian expression system that is capable of generating high levels of expressed hepatitis C virus (HCV) proteins which have previously proved difficult to express due to their non-secretory properties. In particular, the invention provides a plasmid for the expression of the HCV second envelope protein (E2) designated p577. This plasmid encodes a recombinant protein comprising the immunoglobulin signal peptide and amino acids 388-664 of the HCV E2 glycoprotein. This unique expression system produces high levels of HCV proteins that are properly processed, glycosylated, and folded.
Control profile
Gregory F Okasinski from Wadsworth, IL, age ~77 Get Report